BACKGROUND AND OBJECTIVES: Dosimetry and treatment frequency are controversial phototherapy issues. Efficacy of dose fractionation on photobiomodulation was evaluated in vitro. STUDY DESIGN/MATERIALS AND METHODS: Human HEP-2 and murine L-929 cell lines were cultured in complete DMEM media. Photoradiation (670 nm, 5 J/cm2/treatment, 50 J/cm2 total energy delivery), was performed varying treatments per 24 hour period: Group I (Controls)-0, Group II-1/d, Group III-2/d, Group IV-4/d. Cell proliferation was measured using Cyquant (fluorescent DNA content) and MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrasolium bromide) assays for 240 hours post therapy. A proliferation index: PI = (#Cells Experimental(t) / #Cells Control(t)) was computed. RESULTS: MTT assay results demonstrated maximal response in Group III (P < 0.05, n = 3). Cyquant maxima occurred in HEP-2 Groups II and III (P < 0.045) and L-929 Group III (P < 0.091). CONCLUSIONS: Cellular response to dose frequency varies. More frequent treatments (2/24 hours) increased metabolism and proliferation in both cell lines. Further investigation of dose fractionation in phototherapy is warranted.
No takes yet. Share an insight, caveat, or question.
Brondon et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: